These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19534662)

  • 21. Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).
    Dai Z; Cai W; Hu F; Lan Y; Li L; Chung C; Caughey B; Zhang K; Tang X
    Curr Mol Med; 2015; 15(10):975-9. PubMed ID: 26592244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
    Barbaro G
    Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinediones in the treatment of HIV/HAART-associated lipodystrophy syndrome.
    Edgeworth A; Treacy MP; Hurst TP
    AIDS Rev; 2013; 15(3):171-80. PubMed ID: 24002201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central obesity and body fat, but not body mass index, are associated with the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor γ gene in a population with a high consumption of saturated and trans-fatty acids.
    Aguayo-Armendáriz J; Montalvo-Corral M; González-Martínez KA; Grijalva-Haro MI; Ballesteros-Vásquez MN; Caire-Juvera G; Moya-Camarena SY
    Nutr Res; 2018 Sep; 57():28-35. PubMed ID: 30122193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.
    Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPARγ Pro12Ala Polymorphism Influences the Relationship between Dietary Fat Intake, Adiposity and Lipid Profile in Patients with Type 2 Diabetes.
    Koohdani F; Sotoudeh G; Kalantar Z; Mansoori A
    Int J Vitam Nutr Res; 2018 Dec; 88(5-6):263-269. PubMed ID: 31188078
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
    Lemoine M; Barbu V; Girard PM; Kim M; Bastard JP; Wendum D; Paye F; Housset C; Capeau J; Serfaty L
    AIDS; 2006 Feb; 20(3):387-95. PubMed ID: 16439872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in adiponectin receptor genes are associated with lipodystrophy-related phenotypes in HIV-infected patients receiving antiretroviral therapy.
    Castilhos JK; Sprinz E; Lazzaretti RK; Kuhmmer R; Mattevi VS
    HIV Med; 2015 Sep; 16(8):494-501. PubMed ID: 26111083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ.
    Božina T; Sertić J; Lovrić J; Jelaković B; Šimić I; Reiner Ž
    Genet Test Mol Biomarkers; 2014 Jan; 18(1):32-40. PubMed ID: 24200052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
    Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
    Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
    Martinez E; Mocroft A; García-Viejo MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Bianchi L; Conget I; Blanch J; Phillips A; Gatell JM
    Lancet; 2001 Feb; 357(9256):592-8. PubMed ID: 11558485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
    Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N
    Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort.
    Poliska S; Penyige A; Lakatos PL; ; Papp M; Palatka K; Lakatos L; Molnar T; Nagy L
    Inflamm Bowel Dis; 2012 Mar; 18(3):472-9. PubMed ID: 21710534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy.
    Mutimura E; Stewart A; Rheeder P; Crowther NJ
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):451-5. PubMed ID: 18077834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):688-94. PubMed ID: 12615670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTO T/A and peroxisome proliferator-activated receptor-γ Pro12Ala polymorphisms but not ApoA1 -75 are associated with better response to lifestyle intervention in Brazilians at high cardiometabolic risk.
    Curti ML; Rogero MM; Baltar VT; Barros CR; Siqueira-Catania A; Ferreira SR
    Metab Syndr Relat Disord; 2013 Jun; 11(3):169-76. PubMed ID: 23438152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of mutations in LMNA, its promoter region, and the cellular retinoic acid binding protein II (CRABP II) in HIV associated lipodystrophy.
    Behrens GM; Genschel J; Schmidt RE; Schmidt HH
    Eur J Med Res; 2003 May; 8(5):221-5. PubMed ID: 12844477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.
    Vidal F; Domingo P; Viladés C; Peraire J; Arnedo M; Alcamí J; Leal M; Villarroya F; Gatell JM
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1365-82. PubMed ID: 21999362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.